EP Patent

EP0393572A2 — Controlled release tablets containing flavoxate

Assigned to Recordati SA · Expires 1990-10-24 · 36y expired

What this patent protects

Tablets for the controlled release of flavoxate hydrochloride particularly suitable for high active principle doses are described. The characteristic components of these tablets are: a matrix allowing gradual release of the active principle contained within it, a suitable binder …

USPTO Abstract

Tablets for the controlled release of flavoxate hydrochloride particularly suitable for high active principle doses are described. The characteristic components of these tablets are: a matrix allowing gradual release of the active principle contained within it, a suitable binder which limits the dimensions of the finished tablet, and an acidifying agent which ensures stability of the active principle with time and improves its release profile by making it independent of the pH.

Drugs covered by this patent

Patent Metadata

Patent number
EP0393572A2
Jurisdiction
EP
Classification
—
Expires
1990-10-24
Drug substance claim
No
Drug product claim
No
Assignee
Recordati SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.